Table: Towa Pharmaceutical -2025/26 parent results

TOWA PHARMACEUTICAL

14/05/2026 07:42

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          182.74          172.27                                
               (+6.1 pct)      (+15.4 pct)                             
  Operating       24.95           23.69                                
               (+5.3 pct)      (+18.7 pct)                             
  Recurring       31.64           27.53                                
               (+14.9 pct)     (+1.1 pct)                              
  Net           loss 1.48         21.10                                
                               (+7.7 pct)                              
  EPS        loss 30.14 yen    428.66 yen                              
  Ann Div       80.00 yen       70.00 yen      85.00 yen               
  -Q2 Div       40.00 yen       30.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       40.00 yen      45.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T